CONMED Corporation (CNMD)

CONMED Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,347	1,307	1,245	1,045	1,011	862.46
Revenue Growth (YoY)	4.61%	5.00%	19.06%	3.45%	17.18%	-9.70%
Cost of Revenue	586.34	573.98	559.9	469.73	442.6	402.16
Gross Profit	761.13	733.03	684.85	575.75	568.04	460.3
Selling, General & Admin	553.15	519.33	504.66	441.42	414.73	374.17
Research & Development	54.16	54.43	52.6	47.15	43.57	40.47
Operating Expenses	607.31	573.75	557.26	488.57	458.29	414.65
Operating Income	153.82	159.28	127.58	87.17	109.74	45.66
Interest Expense	-32.57	-37.3	-39.78	-28.91	-35.49	-44.05
Other Non Operating Income (Expenses)	-0.06	-	-	-	-0.05	-
EBT Excluding Unusual Items	121.19	121.98	87.81	58.27	74.21	1.6
Merger & Restructuring Charges	-30.6	-	-9.4	-14.6	-	-
Other Unusual Items	-5.09	41.05	2.42	-114.53	-1.1	-
Pretax Income	85.51	163.03	80.83	-70.86	73.11	1.6
Income Tax Expense	21.44	30.61	16.37	9.72	10.56	-7.91
Net Income	64.07	132.42	64.46	-80.58	62.54	9.52
Net Income to Common	64.07	132.42	64.46	-80.58	62.54	9.52
Net Income Growth	-51.37%	105.44%	-	-	557.16%	-66.75%
Shares Outstanding (Basic)	31	31	31	30	29	29
Shares Outstanding (Diluted)	31	31	32	30	32	29
Shares Change (YoY)	-0.29%	-1.26%	5.02%	-6.75%	9.34%	-0.10%
EPS (Basic)	2.07	4.29	2.10	-2.68	2.14	0.33
EPS (Diluted)	2.05	4.25	2.04	-2.68	1.94	0.32
EPS Growth	-51.43%	108.33%	-	-	506.25%	-67.01%
Free Cash Flow	148.96	153.88	106.32	11.58	96.9	51.52
Free Cash Flow Per Share	4.78	4.94	3.37	0.39	3.01	1.75
Dividend Per Share	0.800	0.800	0.800	0.800	0.800	0.800
Gross Margin	56.49%	56.08%	55.02%	55.07%	56.21%	53.37%
Operating Margin	11.42%	12.19%	10.25%	8.34%	10.86%	5.29%
Profit Margin	4.75%	10.13%	5.18%	-7.71%	6.19%	1.10%
Free Cash Flow Margin	11.05%	11.77%	8.54%	1.11%	9.59%	5.97%
EBITDA	225.86	229.74	197.76	154.59	177.19	113.58
EBITDA Margin	16.76%	17.58%	15.89%	14.79%	17.53%	13.17%
D&A For EBITDA	72.04	70.46	70.17	67.42	67.44	67.93
EBIT	153.82	159.28	127.58	87.17	109.74	45.66
EBIT Margin	11.42%	12.19%	10.25%	8.34%	10.86%	5.29%
Effective Tax Rate	25.07%	18.77%	20.25%	-	14.45%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q